This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biason-Lauber, A. Articles by Zachmann, M. Search for Related Content PubMed PubMed Citation Articles by Biason-Lauber, A. Articles by Zachmann, M.

17-Hydroxylase/17,20-Lyase Deficiency as a Model to Study Enzymatic Activity Regulation: Role of Phosphorylation¹

Department of Pediatrics, Divisions of Pediatric Endocrinology and Diabetology and Clinical Chemistry and Biochemistry, University of Zurich (A.B.-L., B.K., E.W., M.Z.), 8032 Zurich, Switzerland; Pathologie Hormonale Moleculaire, Hopital Debrousse (M.G.F.), Lyon, France; Divisione di Endocrinologia, Ospedale Infantile Regina Margherita (S.E.), Turin, Italy; Kinderklinik, Eberhard-Karls-Universität Tübingen (M.B.R.), Tubingen, Germany; Department of Pediatrics, Keio University Hospital (N.M.), Tokyo, Japan; and Clinica Pediatrica III, Centro di Endocrinologia Infantile e dell’Adolescenza, Universitá di Milano (V.B.), Milan, Italy

Address all correspondence and requests for reprints to: Dr. Anna Biason-Lauber, Department of Pediatrics, Divisions of Pediatric Endocrinology/Diabetology and Clinical Chemistry and Biochemistry, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland. E-mail: alauber{at}kispi.unizh.ch

Cytochrome P450 17-hydroxylase (CYP17) is a single gene-encoded protein with two activities: 17-hydroxylase and 17,20-lyase. The two catalytic activities are differentially regulated in health and disease. We took advantage of naturally occurring human mutations to understand the molecular bases of this differential regulation. We identified eight novel mutations in the CYP17 gene, different in nature and spread throughout the gene. As posttranslational modifications appear to be important for activity control, we investigated the phosphorylation state of wild-type and mutant CYP17 proteins. Although phospholabeled protein was seen when the wild-type and most mutant proteins were expressed, no phosphorylation was detected for the F417C mutant. F417C is the only 17,20-lyase deficiency case confirmed at the molecular level and represents the first phosphorylation CYP17-deficient mutant. In search of the physiological agents involved in this process, the effect of cAMP was tested on activity and phosphorylation state of our mutant CYP17 proteins. cAMP stimulates activity and phosphorylation in all cases, except in the F417C and R35L mutants. The lack of response to the physiological second messenger might explain the different phenotypes. The F417C mutant protein, which is already shown to be associated with the lack of electron transfer, provides for the first time a link between the electron transfer system and the phosphorylation state of the CYP17 enzyme in the control of 17,20-lyase activity.

This article has been cited by other articles:

				L.-L. Wang, Y. Li, and S.-F. Zhou A Bioinformatics Approach for the Phenotype Prediction of Nonsynonymous Single Nucleotide Polymorphisms in Human Cytochromes P450 Drug Metab. Dispos., May 1, 2009; 37(5): 977 - 991. [Abstract] [Full Text] [PDF]

				D. Tiosano, C. Knopf, I. Koren, N. Levanon, M. F Hartmann, Z. Hochberg, and S. A Wudy Metabolic evidence for impaired 17{alpha}-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity Eur. J. Endocrinol., March 1, 2008; 158(3): 385 - 392. [Abstract] [Full Text] [PDF]

				S. Rosa, C. Duff, M. Meyer, M. Lang-Muritano, G. Balercia, M. Boscaro, A. Kemal Topaloglu, R. Mioni, F. Fallo, L. Zuliani, et al. P450c17 Deficiency: Clinical and Molecular Characterization of Six Patients J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1000 - 1007. [Abstract] [Full Text] [PDF]

				J.-Q. Wei, J.-L. Wei, W.-C. Li, Y.-S. Bi, and F.-C. Wei Genotyping of Five Chinese Patients with 17{alpha}-Hydroxylase Deficiency Diagnosed through High-Performance Liquid Chromatography Serum Adrenal Profile: Identification of Two Novel CYP17 Mutations J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3647 - 3653. [Abstract] [Full Text] [PDF]

				M K Akhtar, S L Kelly, and M A Kaderbhai Cytochrome b5 modulation of 17{alpha} hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis J. Endocrinol., November 1, 2005; 187(2): 267 - 274. [Abstract] [Full Text] [PDF]

				M. J. ten Kate-Booij, C. Cobbaert, J. W. Koper, and F. H. de Jong Deficiency of 17,20-lyase causing giant ovarian cysts in a girl and a female phenotype in her 46,XY sister: Case report Hum. Reprod., February 1, 2004; 19(2): 456 - 459. [Abstract] [Full Text] [PDF]

				M. Costa-Santos, C. E. Kater, and R. J. Auchus Two Prevalent CYP17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 49 - 60. [Abstract] [Full Text] [PDF]

				R. M. Martin, C. J. Lin, E. M. F. Costa, M. L. de Oliveira, A. Carrilho, H. Villar, C. A. Longui, and B. B. Mendonca P450c17 Deficiency in Brazilian Patients: Biochemical Diagnosis through Progesterone Levels Confirmed by CYP17 Genotyping J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5739 - 5746. [Abstract] [Full Text] [PDF]

				E. L. T. van den Akker, J. W. Koper, A. L. M. Boehmer, A. P. N. Themmen, M. Verhoef-Post, M. A. Timmerman, B. J. Otten, S. L. S. Drop, and F. H. De Jong Differential Inhibition of 17{alpha}-Hydroxylase and 17,20-Lyase Activities by Three Novel Missense CYP17 Mutations Identified in Patients with P450c17 Deficiency J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5714 - 5721. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, G. Zhang, and J. C. Garmey Troglitazone, an Insulin-Sensitizing Thiazolidinedione, Represses Combined Stimulation by LH and Insulin of de Novo Androgen Biosynthesis by Thecal Cells in Vitro J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1129 - 1133. [Abstract] [Full Text] [PDF]

				A. Di Cerbo, A. Biason-Lauber, M. Savino, M. R. Piemontese, A. Di Giorgio, M. Perona, and A. Savoia Combined 17{alpha}-Hydroxylase/17,20-Lyase Deficiency Caused by Phe93Cys Mutation in the CYP17 Gene J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 898 - 905. [Abstract] [Full Text] [PDF]

				M. K. Gupta, D. H. Geller, and R. J. Auchus Pitfalls in Characterizing P450c17 Mutations Associated with Isolated 17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4416 - 4423. [Abstract] [Full Text] [PDF]

				P. F. Collett-Solberg Congenital Adrenal Hyperplasia: From Genetics and Biochemistry to Clinical Practice, Part 1 Clinical Pediatrics, January 1, 2001; 40(1): 1 - 16. [Abstract] [PDF]